Heather White
Hoofd Techniek/Wetenschap/O&O bij ALBIREO PHARMA, INC.
Actieve functies van Heather White
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ALBIREO PHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 02-03-2023 | - |
Loopbaan van Heather White
Eerdere bekende functies van Heather White
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AMICUS THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-01-2008 | - |
Schering-Plough Ltd.
 Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | 01-01-1997 | - |
| IPSEN | Comptroller/Controller/Auditor | 01-01-2014 | - |
Opleiding van Heather White
| The University of Liverpool | Graduate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
| Verenigde Staten | 3 |
| Frankrijk | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| IPSEN | Health Technology |
| AMICUS THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Schering-Plough Ltd.
Schering-Plough Ltd. Pharmaceuticals: MajorHealth Technology Schering-Plough Ltd. manufactures and distributes pharmaceutical products. Its products include medicines for vascular diseases, oncology, opioid tendency, sexual health and virology. The company was founded on December 31, 1884 and is headquartered in Walton, the United Kingdom. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
- Beurs
- Insiders
- Heather White
- Ervaring
